Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2382-2021Class II

EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128

Theratest Laboratories, Inc. / initiated 2020-10-05 / Terminated

Thera Test Laboratories, Inc. began a recall of EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128 on . FDA classified it as Class II and gives the reason as "The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2382-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Theratest Laboratories, Inc.
Product
EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128
Product code
QKO Reagent, Coronavirus Serological
Reason for recall
The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128
FDA root cause
No Marketing Application
Action
The firm initiated the recall using undated letters attached to emails sent on 10/7/2020 requesting return of product.
Quantity in commerce
19 kits
Distribution
US Nationwide distribution in the states of California, Florida, Illinois, Indiana, North Carolina, and Texas.
Product codes and lots
Lot numbers 05204351, exp. 5/1/2021, and 05204368, exp. 05/19/2021.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2382-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2382-2021Class IITerminatedVoluntary: Firm initiated